{
    "2021-09-29": [
        [
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)首次海外授权！口服GLP-1创新药TTP273进军韩国市场",
                "features": {
                    "keywords": [
                        "华东医药",
                        "海外授权",
                        "GLP-1",
                        "创新药",
                        "TTP273",
                        "韩国市场"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：子公司与DaeWon签署产品独家授权许可协议",
                "features": {
                    "keywords": [
                        "华东医药",
                        "子公司",
                        "DaeWon",
                        "独家授权",
                        "许可协议"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "国际合作",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药最新公告：子公司奥硝唑片通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "华东医药",
                        "子公司",
                        "奥硝唑片",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "仿制药",
                        "一致性评价"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)：奥硝唑片通过仿制药质量和疗效一致性评价",
                "features": {
                    "keywords": [
                        "华东医药",
                        "奥硝唑片",
                        "仿制药",
                        "质量和疗效",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "仿制药",
                        "一致性评价"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药奥硝唑片通过一致性评价 强化抗感染类产品线市场竞争",
                "features": {
                    "keywords": [
                        "华东医药",
                        "奥硝唑片",
                        "一致性评价",
                        "抗感染类",
                        "市场竞争"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "仿制药",
                        "抗感染类药物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：中美华东与DaeWon签署产品独家授权许可协议",
                "features": {
                    "keywords": [
                        "华东医药",
                        "中美华东",
                        "DaeWon",
                        "独家授权",
                        "许可协议"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "国际合作",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}